Hyperimmune Plasma for Patients With COVID-19
Clinical trial NCT04614012 · UNKNOWN
Trial details
- NCT number
- NCT04614012
- Sponsor
- ANNA FALANGA
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-02
- Primary completion
- 2022-07-02
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.